[Response to Terlipressin and albumin is associated with improved outcome in patients with cirrhosis and hepatorenal syndrome].

Background And Aim: Hepatorenal syndrome (HRS) is a severe but potentially reversible complication in patients with cirrhosis. Untreated it is associated with a poor prognosis. Several randomized controlled trials (RCT) demonstrated that treatment with terlipressin and albumin improves renal function.